| Betterchem |

|
|
|
| FDA approval activities
for this prescription drug:
VIRACEPT (nelfinavir mesylate) Tablets, 625 mg, Agouron NDA 21-503 4/30/03 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-779/S41 20-778/S20 & 21-503/S2 8/22/03 8/28/03 8/28/03 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-779/S22 4/23/03 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S18 & 20-779/S39 12/20/02 7/30/03 4/4/03 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S16, 20-778/S17, 20-779/S37 & 20-779/S38 2/5/02 4/17/02 VIRACEPT (nelfinavir mesylate) Tablets and Powder, 250mg & 50mg/g Agouron NDA 20-778/S14, 20-779/S32 |
© 2009 Betterchem.com
|